Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +37.44%
#3 Glidr Glidr +35.94%
#4 Humanity Humanity +25.03%
#5 Tutorial Tutorial +21.66%
#6 Enso Enso +21.56%
#7 Codatta Codatta +19.97%
#8 Walrus Walrus +19.47%
#9 BOOK OF MEME BOOK OF MEME +18.59%
#10 Ribbita by Virtuals Ribbita by Virtuals +13.44%
Coin of the day
EXOD EXOD
설정
언어
한국어
통화
USD
테마
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
주식 순위 #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
주가
$0.6
마지막 동기화: 2024-08-14
시가총액
$2.09M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
SG
거래 ASLAN Pharmaceuticals Limited (ASLN)

카테고리

Healthcare
ASLAN Pharmaceuticals Limited (ASLN)의 수익
Mar 2024 기준 수익 TTM: $-34.90M
ASLAN Pharmaceuticals Limited의 최신 재무 보고서에 따르면 회사의 현재 수익은 $-34.90M입니다. 2022년에 회사는 $-51.28M의 수익을 올렸으며 이는 2021년의 수익 $-31.59M과 감소입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
ASLAN Pharmaceuticals Limited의 수익 기록 (2014 ~ 2026)
연말 수익
연도 수익 변화
2026 (TTM) $-34.90M -20.84%
2023 $-44.09M -14.03%
2022 $-51.28M 62.34%
2021 $-31.59M 86.14%
2020 $-16.97M -63.63%
2019 $-46.66M 10.64%
2018 $-42.17M 3.58%
2017 $-40.71M 352.17%
2016 $-9.00M -32.43%
2015 $-13.33M 80.95%
2014 $-7.36M 0.00%
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -15,214.03%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -5,689.14%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -8,712.20%
BE